Topics
Glioblastoma | Treatment | Clinical trials | Drug delivery
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Drug delivery
Truusalu JP, Oselin K, Lass J, Buck KK, Sietsema W, Soeorg H,
Toome K, Kaarna K, Teesalu T, Kõrgvee LT.
LSTA1-GBM-2A:
study protocol for an exploratory phase 2a randomised controlled
trial evaluating tumour-homing peptide certepetide with
temozolomide in glioblastoma multiforme.
BMJ
Open. 2025 Nov 13;15(11):e106094. doi:
10.1136/bmjopen-2025-106094. PMID:
41248393. Interventional study protocol. ˍ